Clinical Trial Details

EORTC-1532-GUCG

Back to Clinical Trials Database

A phase 2 Randomized Open-Label Study of Oral darolutamide (ODM-201) vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in Men with Hormone Naive Prostate Cancer

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 01-Dec-2017
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 250 - All Groups: 250
Treatment Drug
Goserelin, Triptorelin, Leuprorelin, Degarelix, ODM-201
Study Staff Bertrand Tombal (Study Coordinator) , Cliniques Universitaires Saint-Luc, Brussels
Hazal Erkol (Data Manager) , EORTC Headquarters, Brussels
Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels
Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels
Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Amaya Gonzalez (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels
Joanna Krzystyniak (Clinical Operations Manager) , EORTC Headquarters, Brussels
Belma Malanda (Project Manager) , EORTC Headquarters, Brussels
Barbara Ogrodniczak (Junior Clinical Operations Manager) , ,
Miguel Remis (Lead CRA) , EORTC Headquarters, Brussels
Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Jelle Stans (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Gaetan de Schaetzen (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer Prostate
Participating groups EORTC Genito-Urinary Cancers Group
DEUTSCHE URO-ONKOLOGEN E.V.
Recruiting centers Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale Molinette (Torino, Italy)
CHU Mont Godinne - UCL Namur (Yvoir, Belgium)
CHU de Limoges - Hopital Dupuytren (LIMOGES CEDEX 1, France)
Centre Georges-Francois-Leclerc (DIJON CEDEX, France)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
Fundacion Instituto Valenciano De Oncologia (Valencia, Spain)
Gustave Roussy (VILLEJUIF CEDEX, France)
Hopital Universitaires Erasme (Brussels, Belgium)
Hospital Universitario Ramon y Cajal (Madrid, Spain)
Hospital Universitario Virgen De La Victoria (Malaga, Spain)
Hospital Universitario de Salamanca - Hosp Virgen De la Vega (Salamanca, Spain)
ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
National Cancer Institute - Cairo (Cairo, Egypt)
Universitair Ziekenhuis Gent (Gent, Belgium)
Protocol summary http://clinicaltrials.gov/study/NCT02972060
NCT number NCT02972060
EudraCT 2016-004334-17
Financial Support Educational Grant